Results and lessons learnt from a randomized controlled trial: prophylactic treatment of vestibular migraine with metoprolol (PROVEMIG)
Abstract Background Vestibular migraine (VM) is the most frequent cause of recurrent spontaneous attacks of vertigo causally related to migraine. The objective of the Prophylactic treatment of vestibular migraine with metoprolol (PROVEMIG) trial was to demonstrate that metoprolol succinate is superi...
Main Authors: | Otmar Bayer, Christine Adrion, Amani Al Tawil, Ulrich Mansmann, Michael Strupp, PROVEMIG investigators |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-12-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-019-3903-5 |
Similar Items
-
Correlation of vestibular symptoms and headache in migraine patients: a clinical study of 424 cases
by: LIU Juan, et al.
Published: (2021-04-01) -
Current treatment options in vestibular migraine
by: Mark eObermann, et al.
Published: (2014-12-01) -
Vestibular migraine
by: Santosh Kumar Swain, et al.
Published: (2021-01-01) -
Migraine and episodic Vertigo: a cohort survey study of their relationship
by: Christian Lampl, et al.
Published: (2019-04-01) -
Vestibular migraine: Considered from both the vestibular and the migraine point of view
by: Gulden Akdal, et al.
Published: (2020-01-01)